NanoVibronix, Inc. generated $2.6M in revenue in fiscal year 2025. This represents a decrease of 0.2% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $2.2M in revenue. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters NanoVibronix, Inc. has filed alongside them.
Ticker history: NAOV became FEED (ENvue Medical Inc New) on .
Annual figures, oldest first. Point at a bar to read its period.
NAOV Revenue by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
NAOV Revenue by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More NanoVibronix, Inc. financials
Frequently Asked Questions
NanoVibronix, Inc. generated $2.6M in revenue in fiscal year 2025.
NanoVibronix, Inc. (NAOV) revenue fell by 0.2% year over year, from $2.6M to $2.6M in fiscal year 2025.
NanoVibronix, Inc. (NAOV) reported $2.2M in revenue over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
Across the 12 fiscal years this page covers, NanoVibronix, Inc. (NAOV) revenue went from $203K in fiscal year 2014 to $2.6M in fiscal year 2025.
NanoVibronix, Inc. (NAOV) reported $653K in revenue in Q1 2026. This represents a decrease of 36.3% from the same quarter a year earlier.
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what NanoVibronix, Inc. (NAOV) reported on that line in every period on record.